rs11078659

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_000697.3(ALOX12):​c.951+146G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.488 in 903,006 control chromosomes in the GnomAD database, including 109,812 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.48 ( 17736 hom., cov: 32)
Exomes 𝑓: 0.49 ( 92076 hom. )

Consequence

ALOX12
NM_000697.3 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.370

Publications

5 publications found
Variant links:
Genes affected
ALOX12 (HGNC:429): (arachidonate 12-lipoxygenase, 12S type) This gene encodes a member of the lipoxygenase family of proteins. The encoded enzyme acts on different polyunsaturated fatty acid substrates to generate bioactive lipid mediators including eicosanoids and lipoxins. The encoded enzyme and its reaction products have been shown to regulate platelet function. Elevated expression of this gene has been observed in pancreatic islets derived from human diabetes patients. Allelic variants in this gene may be associated with susceptibility to toxoplasmosis. Multiple pseudogenes of this gene have been identified in the human genome. [provided by RefSeq, Aug 2017]
MIR497HG (HGNC:39523): (mir-497-195 cluster host gene)
ALOX12-AS1 (HGNC:51342): (ALOX12 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 17-7000625-G-A is Benign according to our data. Variant chr17-7000625-G-A is described in ClinVar as [Benign]. Clinvar id is 1179701.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.505 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALOX12NM_000697.3 linkc.951+146G>A intron_variant Intron 7 of 13 ENST00000251535.11 NP_000688.2 P18054
ALOX12-AS1NR_040089.1 linkn.233+9171C>T intron_variant Intron 2 of 2
ALOX12XM_011523780.3 linkc.744+146G>A intron_variant Intron 6 of 12 XP_011522082.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALOX12ENST00000251535.11 linkc.951+146G>A intron_variant Intron 7 of 13 1 NM_000697.3 ENSP00000251535.6 P18054

Frequencies

GnomAD3 genomes
AF:
0.482
AC:
73087
AN:
151752
Hom.:
17722
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.469
Gnomad AMI
AF:
0.467
Gnomad AMR
AF:
0.396
Gnomad ASJ
AF:
0.478
Gnomad EAS
AF:
0.410
Gnomad SAS
AF:
0.497
Gnomad FIN
AF:
0.505
Gnomad MID
AF:
0.522
Gnomad NFE
AF:
0.509
Gnomad OTH
AF:
0.484
GnomAD4 exome
AF:
0.489
AC:
367265
AN:
751136
Hom.:
92076
AF XY:
0.490
AC XY:
186770
AN XY:
381062
show subpopulations
African (AFR)
AF:
0.456
AC:
8319
AN:
18230
American (AMR)
AF:
0.317
AC:
6620
AN:
20888
Ashkenazi Jewish (ASJ)
AF:
0.479
AC:
7389
AN:
15432
East Asian (EAS)
AF:
0.460
AC:
15206
AN:
33042
South Asian (SAS)
AF:
0.505
AC:
26526
AN:
52566
European-Finnish (FIN)
AF:
0.519
AC:
19098
AN:
36804
Middle Eastern (MID)
AF:
0.532
AC:
1348
AN:
2536
European-Non Finnish (NFE)
AF:
0.496
AC:
265689
AN:
535966
Other (OTH)
AF:
0.479
AC:
17070
AN:
35672
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
8852
17704
26557
35409
44261
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5750
11500
17250
23000
28750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.482
AC:
73143
AN:
151870
Hom.:
17736
Cov.:
32
AF XY:
0.480
AC XY:
35637
AN XY:
74178
show subpopulations
African (AFR)
AF:
0.469
AC:
19408
AN:
41388
American (AMR)
AF:
0.395
AC:
6026
AN:
15250
Ashkenazi Jewish (ASJ)
AF:
0.478
AC:
1661
AN:
3472
East Asian (EAS)
AF:
0.411
AC:
2117
AN:
5154
South Asian (SAS)
AF:
0.497
AC:
2392
AN:
4810
European-Finnish (FIN)
AF:
0.505
AC:
5319
AN:
10526
Middle Eastern (MID)
AF:
0.527
AC:
154
AN:
292
European-Non Finnish (NFE)
AF:
0.509
AC:
34622
AN:
67962
Other (OTH)
AF:
0.484
AC:
1018
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1960
3920
5880
7840
9800
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
672
1344
2016
2688
3360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.498
Hom.:
27875
Bravo
AF:
0.466
Asia WGS
AF:
0.442
AC:
1542
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
2.2
DANN
Benign
0.57
PhyloP100
-0.37
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11078659; hg19: chr17-6903944; COSMIC: COSV52351729; COSMIC: COSV52351729; API